{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:04:05Z","timestamp":1784351045256,"version":"3.55.0"},"reference-count":23,"publisher":"Nihon University School of Dentistry","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Sci","Journal of Oral Science"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2334\/josnusd.25-0334","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:09:19Z","timestamp":1780092559000},"page":"135-139","source":"Crossref","is-referenced-by-count":0,"title":["Effects of oren on IL-6 production in cultured human airway epithelial cells stimulated with the SARS-CoV-2 envelope protein"],"prefix":"10.2334","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2010-745X","authenticated-orcid":false,"given":"Hourei","family":"Oh","sequence":"first","affiliation":[{"name":"The Center of Innovation in Dental Education, Osaka Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4732-8145","authenticated-orcid":false,"given":"Yoshimasa","family":"Makita","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Osaka Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-8022","authenticated-orcid":false,"given":"Kazuya","family":"Masuno","sequence":"additional","affiliation":[{"name":"The Center of Innovation in Dental Education, Osaka Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8755-9898","authenticated-orcid":false,"given":"Yasuhiro","family":"Imamura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Matsumoto Dental University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1160","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Siddiqi HK, Mehra MR (2020) COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 39, 405-407. doi: 10.1016\/j.healun.2020.03.012","DOI":"10.1016\/j.healun.2020.03.012"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Gandhi RT, Lynch JB, Del Rio C (2020) Mild or moderate Covid-19. N Engl J Med 383, 1757-1766. doi: 10.1056\/NEJMcp2009249","DOI":"10.1056\/NEJMcp2009249"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Takayama S, Namiki T, Odaguchi H, Arita R, Hisanaga A, Mitani K et al. (2021) Prevention and recovery of COVID-19 patients with Kampo medicine: review of case reports and ongoing clinical trials. Front Pharmacol 12, 656246. doi: 10.3389\/fphar.2021.656246","DOI":"10.3389\/fphar.2021.656246"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ono R, Arita R, Takayama S, Kanno T, Kikuchi A, Suzuki S (2023) Progress and treatment of \u201clong COVID\u201d in non-hospitalized patients: a single-center retrospective cohort study. Trad Kampo Med 10, 150-158. doi: 10.1002\/tkm2.1370","DOI":"10.1002\/tkm2.1370"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Ara T, Honjo K, Fujinami Y, Hattori T, Imamura Y, Wang PL (2010) Preventive effects of a Kampo medicine, Orento, on inflammatory responses in lipopolysaccharide-treated human gingival fibroblasts. Biol Pharm Bull 33, 611-616. doi: 10.1248\/bpb.33.611","DOI":"10.1248\/bpb.33.611"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Oh H, Masuno K, Okusa N, Makita Y, Fujiwara S, Imamura Y (2020) Effect of Orento, a traditional Japanese medicine, on IL-6, IL-8 secretion, type 1 collagen production and alkaline phosphatase secretion in the human osteosarcoma cell line Saos-2. Medicines 7, 61. doi: 10.3390\/medicines7100061","DOI":"10.3390\/medicines7100061"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Imamura Y, Makita Y, Masuno K, Oh H (2023) Inhibitory mechanism of IL-6 production by Orento in oral squamous cell carcinoma cell line CAL27 stimulated by pathogen-associated molecular patterns from periodontopathogenic Porphyromonas gingivalis. Int J Mol Sci 24, 697. doi: 10.3390\/ijms24010697","DOI":"10.3390\/ijms24010697"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW et al. (2019) Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol 57, 193-225. doi: 10.1080\/13880209.2019.1577466","DOI":"10.1080\/13880209.2019.1577466"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507-513. doi: 10.1016\/S0140-6736(20)30211-7","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y et al. (2020) Detectable serum SARS-coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis 71, 1937-1942. doi: 10.1093\/cid\/ciaa449","DOI":"10.1093\/cid\/ciaa449"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. McGonagle D, Sharif K, O\u2019Regan A, Bridgewood C (2020) The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 19, 102537. doi: 10.1016\/j.autrev.2020.102537","DOI":"10.1016\/j.autrev.2020.102537"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Zheng M, Karki R, Williams EP, Yang D, Fitzpatrick E, Vogel P et al. (2021) TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol 22, 829-838. doi: 10.1038\/s41590-021-00937-x","DOI":"10.1038\/s41590-021-00937-x"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Plan\u00e8s R, Bert JB, Tairi S, BenMohamed L, Bahraoui E (2022) SARS-CoV-2 envelope (E) protein binds and activates TLR2 pathway: a novel molecular target for COVID-19 interventions. Viruses 14, 999. doi: 10.3390\/v14050999","DOI":"10.3390\/v14050999"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Aiewsakun P, Phumiphanjarphak W, Ludowyke N, Purwono PB, Manopwisedjaroen S, Srisaowakarn C et al. (2023) Systematic exploration of SARS-CoV-2 adaptation to Vero E6, Vero E6\/TMPRSS2, and Calu-3 cells. Genome Biol Evol 15, evad035. doi: 10.1093\/gbe\/evad035","DOI":"10.1093\/gbe\/evad035"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Imamura Y, Wang PL (2014) Salivary histatin 3 inhibits heat shock cognate protein 70-mediated inflammatory cytokine production through toll-like receptors in human gingival fibroblasts. J Inflamm (Lond) 11, 4. doi: 10.1186\/1476-9255-11-4","DOI":"10.1186\/1476-9255-11-4"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Imamura Y, Katahira T, Kitamura D (2004) Identification and characterization of a novel BASH N terminus-associated protein, BNAS2. J Biol Chem 279, 26425-26432. doi: 10.1074\/jbc.M403685200","DOI":"10.1074\/jbc.M403685200"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10, 2327-2334. doi: 10.1128\/mcb.10.5.2327-2334.1990","DOI":"10.1128\/mcb.10.5.2327-2334.1990"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Kashiwasda M, Shirakata Y, Inoue JI, Nakano H, Okazaki K, Okumura K et al. (1998) Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway. J Exp Med 187, 237-244. doi: 10.1084\/jem.187.2.237","DOI":"10.1084\/jem.187.2.237"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Tsui KH, Feng TH, Hsieh WC, Chang PL, Juang HH (2008) Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells. Acta Pharmacol Sin 29, 1334-1341. doi: 10.1111\/j.1745-7254.2008.00887.x","DOI":"10.1111\/j.1745-7254.2008.00887.x"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Gupta SC, Sundaram C, Reuter S, Aggarwal BB (2010) Inhibiting NF-\u03baB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 1799, 775-787. doi: 10.1016\/j.bbagrm.2010.05.004","DOI":"10.1016\/j.bbagrm.2010.05.004"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Bensaude O (2011) Inhibiting eukaryotic transcription: which compound to choose? How to evaluate its activity? Transcription 2, 103-108. doi: 10.4161\/trns.2.3.16172","DOI":"10.4161\/trns.2.3.16172"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Ryan CT, Lippard SJ (2009) Inhibition of transcription by platinum antitumor compounds. Metallomics 1, 280-291. doi: 10.1039\/b907567d","DOI":"10.1039\/b907567d"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Evans DM, Fang J, Silvers T, Delosh R, Laudeman J, Ogle C et al. (2019) Exposure time versus cytotoxicity for anticancer agents, Cancer Chemother Pharmacol 84, 359-371. doi: 10.1007\/s00280-019-03863-w","DOI":"10.1007\/s00280-019-03863-w"}],"container-title":["Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/josnusd\/68\/3\/68_25-0334\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:51:27Z","timestamp":1784350287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/josnusd\/68\/3\/68_25-0334\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2334\/josnusd.25-0334","relation":{},"ISSN":["1343-4934","1880-4926"],"issn-type":[{"value":"1343-4934","type":"print"},{"value":"1880-4926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-0334"}}